Preventing Squamous Cell Skin Cancer
NCT02347813
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Squamous Cell Carcinoma of the Skin
Interventions
DRUG:
Pioglitazone
Sponsor
University of Rochester